Allterum Therapeutics receives $12 million product development grant from CPRIT to advance anti-CD127 therapeutic antibody into clinic

Allterum Therapeutics, Inc. has been awarded a $12 million product development grant from the Cancer Prevention and Research Institute of Texas (CPRIT). This grant will support the clinical evaluation of Allterum's 4A10 monoclonal antibody targeting CD127, a receptor that is expressed in...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: AWD Source Type: news